A Pooled Analysis Evaluating the Efficacy and Tolerability of Tapentadol Extended Release for Chronic, Painful Diabetic Peripheral Neuropathy

Ready Conversion of Patients with Well-Controlled, Moderate to Severe, Chronic Malignant Tumor–related Pain on Other Opioids to Tapentadol Extended Release

(2014) Keiichiro Imanaka et al.   CLINICAL DRUG INVESTIGATION

A Randomized Withdrawal, Placebo-Controlled Study Evaluating the Efficacy and Tolerability of Tapentadol Extended Release in Patients With Chronic Painful Diabetic Peripheral Neuropathy

(2014) Aaron I. Vinik et al.   DIABETES CARE

Tapentadol Prolonged Release Versus Strong Opioids for Severe, Chronic Low Back Pain: Results of an Open-Label, Phase 3b Study

(2013) Rafael Gálvez et al.   ADVANCES IN THERAPY

Relationship Between Pain Relief and Improvements in Patient Function/Quality of Life in Patients With Painful Diabetic Peripheral Neuropathy or Postherpetic Neuralgia Treated With Pregabalin

(2013) Aaron Vinik et al.   CLINICAL THERAPEUTICS

Efficacy and safety of oral tapentadol extended release in Japanese and Korean patients with moderate to severe, chronic malignant tumor-related pain

(2013) Keiichiro Imanaka et al.   CURRENT MEDICAL RESEARCH AND OPINION

Effectiveness and safety of tapentadol prolonged release for severe, chronic low back pain with or without a neuropathic pain component: results of an open-label, phase 3b study

(2012) Ilona Steigerwald et al.   CURRENT MEDICAL RESEARCH AND OPINION

Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management

(2011) S. Tesfaye et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Pharmacological Treatment of Diabetic Neuropathic Pain

(2011) Howard S. Smith et al.   DRUGS

Evidence-based guideline: Treatment of painful diabetic neuropathy: Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation

(2011) V. Bril et al.   NEUROLOGY

Efficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back pain

(2010) Bernd Lange et al.   ADVANCES IN THERAPY

Efficacy and Safety of Tapentadol Extended Release Compared with Oxycodone Controlled Release for the Management of Moderate to Severe Chronic Pain Related to Osteoarthritis of the Knee

(2010) Marc Afilalo et al.   CLINICAL DRUG INVESTIGATION

Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial

(2010) Sherwyn Schwartz et al.   CURRENT MEDICAL RESEARCH AND OPINION

Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study

(2010) Robert Buynak et al.   EXPERT OPINION ON PHARMACOTHERAPY

The Approach to the Management of the Patient with Neuropathic Pain

(2010) Aaron Vinik   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature Update

(2010) Robert H. Dworkin et al.   MAYO CLINIC PROCEEDINGS

Long-term Safety and Tolerability of Tapentadol Extended Release for the Management of Chronic Low Back Pain or Osteoarthritis Pain

(2010) James E. Wild et al.   Pain Practice

Interpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials: IMMPACT Recommendations

(2007) Robert H. Dworkin et al.   JOURNAL OF PAIN

Painful Diabetic Neuropathy: Epidemiology, Natural History, Early Diagnosis, and Treatment Options

(2007) Aristidis Veves et al.   PAIN MEDICINE